States and is a matter of public and societal concern. Our registry report shows that kernicterus, in its usually recognized form, occurs and results in neonatal death or multisystem disabilities, including irreversible athetoid cerebral palsy with speech, and ocular and hearing impairments. A range of total serum bilirubin (TSB) levels, rather than a specific level, was identified as a threshold for the onset of neurotoxicity in otherwise-healthy term infants. Most frequent clinical factors were late prematurity, undiagnosed hemolytic disease, genetic abnormalities (such as glucose 6-phosphate dehydrogenase deficiency, congenital spherocytosis, galactosemia, Crigler-Najjar syndrome and others that are undiagnosed) and concurrent complications of dehydration, sepsis, or acidosis, hypoalbuminemia or poor feeding. Case reports of kernicterus were unusual and rarely identified in healthy infants when TSB levels were <25 mg per 100 ml and none are reported for infants with TSB levels <20 mg per 100 ml. All infants who presented with TSB levels >35 mg per 100 ml sustained some degree of post-icteric sequelae regardless of treatment. Vulnerability to chronic sequelae, in infants with TSB levels between 20 and 35 mg per 100 ml, was influenced by post-natal age, rate of TSB rise, duration of extreme hyperbilirubinemia, late prematurity (p37 weeks), gender (male), being large for gestational age, dehydration (>15% weight loss over birth weight) and infection that was often associated with genetic abnormalities. Our review confirms the narrow margin of safety, especially in infants with TSB levels X25 and <35 mg per 100 ml among whom bilirubin neurotoxicity was potentially reversible. The data also indicate that the 1994 American Academy of Pediatrics guidelines for the management of neonatal jaundice 3 were not implemented by majority of care providers for the infants enrolled in our convenience sample. Most of these infants were admitted with overt clinical signs of progressive acute bilirubin encephalopathy.
In analogy to aviation safety standards, acute kernicterus events are akin to airline crashes. Our evidentiary analysis of 125 cases (composed of cases reported in the literature or to the investigators and included on the basis of strict eligibility criteria of kernicterus) represents the ultimate examples of the failure of an otherwise-safe newborn health-care system. We report that these infants, based on bilirubin screening in the context of gestational age, could have been identified to be at risk for subsequent hyperbilirubinemia (Figure 1 ). Timely access to emergency clinical services was complicated in most infants because of the narrow margin of safety between onset of acute bilirubin encephalopathy and irreversible brain damage. It is also notable that in 8 of the 125 cases, urgent implementation of crash-cart management (stat intensive phototherapy, preparation for an exchange transfusion and an urgent initiation of the exchange within 6-8 h of patient identification) could have resulted in reversible brain injury.
We identified the underlying root cause as a systems failure in neonatal care, especially during the first week after birth. Primarily, multiple providers provided health services at multiple sites. Second, there was insufficient understanding and knowledge about the potential of bilirubin neurotoxicity in the professional community of physicians, nurses, maternal child health-care providers, child health advocates, lactation consultants as well as third party payors and the lay society. The resultant interacting root causes included (a) early hospital discharge at <72 h of age (before the extent of jaundice and hyperbilirubinemia is known); (b) the lack of adequate concern for the risks of severe jaundice in healthy term and late pre-term newborns; (c) a laudable increase in breast feeding but without support and counseling or adequate and optimal lactation; (d) perceived medical cost constraints complicating reimbursement for follow-up at 3 to 5 days of age; (e) paucity of educational materials to enable and empower families; and (f) limitations within health-care systems to provide pre-discharge screening and identification of families and infants at increased risk to ensure post-discharge follow-up.
To address these root causes we have developed a model for a family-centered, system-based approach that builds constructive parent/health-care partnerships aimed at the prevention of bilirubin-induced neurologic dysfunction and related disabilities. A safety and family education program for the management of newborn jaundice, proposed by our team, has been extensively incorporated in the 2004 American Academy of Pediatrics guidelines 2 and made available through the Centers for Disease Control and Prevention website (http://www.cdc.gov/ncbddd/dd/ kernichome.htm). In addition, publications in the pediatric and nursing literatures serve as practical and proven teaching modules. Recent observations suggest that infants with TSB levels >25 mg per 100 ml without acute bilirubin encephalopathy may escape post-icteric consequences of extreme hyperbilirubinemia when provided medical interventions. 6, 7 We propose that, infants with TSB levels X25 mg per 100 ml, and/or possible acute bilirubin encephalopathy, can be designated as sentinel triggers for 'nearmiss' events for kernicterus. As practitioners and health-care systems track these events for institutional or practice surveillance, these indices will be helpful to define indices safer prevention strategies that could reduce rates of readmission for phototherapy while preventing overuse and abuse of phototherapy. 8 A better understanding of a life-long follow-up of these infants during their infancy, childhood and adolescence is needed to explore future strategies for neurological restoration and possible developmental antecedents for adult-onset sequelae.
In the meantime, cases of acute kernicterus and near-miss kernicterus continue to be reported by co-workers. To best prevent future kernicterus tragedies in the twenty-first century, effective Figure 1 A schematic diagram of pre-discharge TcB/TSB (total serum bilirubin) guideline to assess the risk for subsequent hyperbilirubinemia (>95th percentile for age in hours beyond 72 h of age) and concurrent recommendations for repeat checks for TcB/TSB until bilirubin levels are in the low-risk zone. 4, 5 strategies to implement and institutionalize the evidence-based and consensus-driven guidelines for safer management of newborn jaundice (Table 1) are needed and should be complemented with practice-based surveillance use of phototherapy and incidence of near-miss events.
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